ESC Professional Premium Access

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Ms Elisavet Angeli

University of Copenhagen, Copenhagen (Denmark)
1 presentation
0 follower

6 more presentations in this session

Baseline profile and results of atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy

Speaker: Ms T. Gonzalez Ferrero (Santiago de Compostela, ES)


Aggressive combined pharmacotherapy for heart failure reduces new onset atrial fibrillation

Speaker: Doctor M. Tokutome (Fukuoka, JP)


Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Speaker: Doctor M. Iguchi (Kyoto, JP) Doctor M. Akao (Kyoto, JP)


ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

Speaker: Doctor N. Bonini (Modena, IT)


Survival among people with heart failure and atrial fibrillation; a population cohort study

Speaker: Doctor N. Jones (Oxford, GB)


Access the full session

Chronic heart failure and atrial fibrillation

Speakers: Ms E. Angeli, Ms T. Gonzalez Ferrero, Doctor M. Tokutome, Doctor M. Iguchi, Doctor M. Akao...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb